Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
If a widely used metabolic drug class is now associated with better long-term survival and lower recurrence in selected breast cancer populations, that naturally raises questions about whether these agents could eventually become part of supportive or even adjunct oncologic care
They partner with telehealth providers for easy access
Drugs (2015) 75:126980
[57] Ambery, P
US$ 29.39
US$ 24.22
US$ 28.21
